ATE224875T1 - Acylaminoalkenylen-amid-derivate als nk1 und nk2 antagonisten - Google Patents
Acylaminoalkenylen-amid-derivate als nk1 und nk2 antagonistenInfo
- Publication number
- ATE224875T1 ATE224875T1 AT97918984T AT97918984T ATE224875T1 AT E224875 T1 ATE224875 T1 AT E224875T1 AT 97918984 T AT97918984 T AT 97918984T AT 97918984 T AT97918984 T AT 97918984T AT E224875 T1 ATE224875 T1 AT E224875T1
- Authority
- AT
- Austria
- Prior art keywords
- acylaminoalkenylene
- antagonists
- amide derivatives
- amide
- derivatives
- Prior art date
Links
- 150000001408 amides Chemical class 0.000 title 1
- 239000005557 antagonist Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D209/20—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals substituted additionally by nitrogen atoms, e.g. tryptophane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D209/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an alkyl or cycloalkyl radical attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D223/06—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D223/12—Nitrogen atoms not forming part of a nitro radical
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH206196 | 1996-08-22 | ||
| PCT/EP1997/004436 WO1998007694A1 (en) | 1996-08-22 | 1997-08-13 | Acylaminoalkenylene-amide derivatives as nk1 and nk2 antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE224875T1 true ATE224875T1 (de) | 2002-10-15 |
Family
ID=4225003
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT97918984T ATE224875T1 (de) | 1996-08-22 | 1997-08-13 | Acylaminoalkenylen-amid-derivate als nk1 und nk2 antagonisten |
Country Status (31)
| Country | Link |
|---|---|
| US (1) | US6319917B1 (de) |
| EP (1) | EP0923550B1 (de) |
| JP (1) | JP3654908B2 (de) |
| KR (1) | KR100467402B1 (de) |
| CN (1) | CN1119328C (de) |
| AR (1) | AR009266A1 (de) |
| AT (1) | ATE224875T1 (de) |
| AU (1) | AU721850B2 (de) |
| BR (1) | BR9711350A (de) |
| CA (1) | CA2264065C (de) |
| CO (1) | CO4900047A1 (de) |
| CZ (1) | CZ294233B6 (de) |
| DE (1) | DE69715886T2 (de) |
| DK (1) | DK0923550T3 (de) |
| ES (1) | ES2184083T3 (de) |
| HU (1) | HU226395B1 (de) |
| ID (1) | ID18059A (de) |
| IL (1) | IL128631A (de) |
| MY (1) | MY132550A (de) |
| NO (1) | NO312292B1 (de) |
| NZ (1) | NZ334736A (de) |
| PE (1) | PE107498A1 (de) |
| PL (1) | PL193731B1 (de) |
| PT (1) | PT923550E (de) |
| RU (1) | RU2185375C2 (de) |
| SI (1) | SI0923550T1 (de) |
| SK (1) | SK283991B6 (de) |
| TR (1) | TR199900363T2 (de) |
| TW (1) | TW438777B (de) |
| WO (1) | WO1998007694A1 (de) |
| ZA (1) | ZA977493B (de) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6281300B1 (en) * | 1998-03-20 | 2001-08-28 | Exxon Chemical Patents, Inc. | Continuous slurry polymerization volatile removal |
| GB0010958D0 (en) * | 2000-05-05 | 2000-06-28 | Novartis Ag | Organic compounds |
| GB0203061D0 (en) * | 2002-02-08 | 2002-03-27 | Novartis Ag | Organic compounds |
| GB0224788D0 (en) * | 2002-10-24 | 2002-12-04 | Novartis Ag | Organic compounds |
| GB2394417A (en) * | 2002-10-24 | 2004-04-28 | Novartis Ag | Solid dispersion comprising a piperidine substance P antagonist and a carrier |
| EP1686985A2 (de) | 2003-10-27 | 2006-08-09 | Novartis AG | Verwendung von neurokinin-antagonisten bei der behandlung von harninkontinenz |
| RU2365585C2 (ru) * | 2003-12-01 | 2009-08-27 | Кембридж Энтерпрайз Лимитед | Противовоспалительные средства |
| DK1691814T3 (da) * | 2003-12-01 | 2012-10-29 | Cambridge Entpr Ltd | Antiinflammatoriske midler |
| GB0402679D0 (en) * | 2004-02-06 | 2004-03-10 | Novartis Ag | Organic compounds |
| JO2630B1 (en) | 2006-04-13 | 2012-06-17 | نوفارتيس ايه جي | Organic compounds |
| GB0607532D0 (en) * | 2006-04-13 | 2006-05-24 | Novartis Ag | Organic compounds |
| EP1938804A1 (de) * | 2006-12-22 | 2008-07-02 | Novartis AG | Pharmazeutische Zubereitung enthaltend Neurokinin Antagonist |
| EP2117538A1 (de) | 2007-01-24 | 2009-11-18 | Glaxo Group Limited | Pharmazeutische zusammensetzungen mit 2-methoxy-5- (5-trifluoromethyl-tetrazol-i-yl-benzyl) - (2s-phenyl-piperidin-3s-yl-) |
| UA105182C2 (ru) | 2008-07-03 | 2014-04-25 | Ньюрексон, Інк. | Бензоксазины, бензотиазины и родственные соединения, которые имеют ингибирующую nos активность |
| US20120077803A1 (en) * | 2009-02-24 | 2012-03-29 | Novartis Ag | Uses Of NK Receptor Antagonists |
| RU2697414C1 (ru) * | 2018-05-11 | 2019-08-14 | Общество с ограниченной ответственностью "АЙ БИ ДИ Терапевтикс" | Новый антагонист тахикининовых рецепторов и его применение |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI97540C (fi) * | 1989-11-06 | 1997-01-10 | Sanofi Sa | Menetelmä terapeuttisesti käyttökelpoisten, aromaattisesti substituoitujen piperidiini- ja piperatsiinijohdannaisten valmistamiseksi |
| US5472978A (en) | 1991-07-05 | 1995-12-05 | Merck Sharp & Dohme Ltd. | Aromatic compounds, pharmaceutical compositions containing them and their use in therapy |
| MY110227A (en) * | 1991-08-12 | 1998-03-31 | Ciba Geigy Ag | 1-acylpiperindine compounds. |
| US5217996A (en) | 1992-01-22 | 1993-06-08 | Ciba-Geigy Corporation | Biaryl substituted 4-amino-butyric acid amides |
| EP0716077A1 (de) * | 1994-12-08 | 1996-06-12 | Ciba-Geigy Ag | Aromatisch substituierte Omega-Aminoalkansäureamide und Alkansäurediamide und ihre Verwendung als Renininhibitoren |
| MX9706394A (es) * | 1995-02-22 | 1997-11-29 | Novartis Ag | Compuestos de 1-aril-2-acilamino-etano y su uso como antagonistas de neuroquinina, especialmente neuroquinina-1. |
-
1997
- 1997-08-08 MY MYPI97003625A patent/MY132550A/en unknown
- 1997-08-13 AT AT97918984T patent/ATE224875T1/de active
- 1997-08-13 CN CN97198633A patent/CN1119328C/zh not_active Expired - Fee Related
- 1997-08-13 CZ CZ1999581A patent/CZ294233B6/cs not_active IP Right Cessation
- 1997-08-13 EP EP97918984A patent/EP0923550B1/de not_active Expired - Lifetime
- 1997-08-13 AU AU42993/97A patent/AU721850B2/en not_active Ceased
- 1997-08-13 DE DE69715886T patent/DE69715886T2/de not_active Expired - Lifetime
- 1997-08-13 BR BR9711350A patent/BR9711350A/pt not_active IP Right Cessation
- 1997-08-13 JP JP51037198A patent/JP3654908B2/ja not_active Expired - Lifetime
- 1997-08-13 TR TR1999/00363T patent/TR199900363T2/xx unknown
- 1997-08-13 DK DK97918984T patent/DK0923550T3/da active
- 1997-08-13 SI SI9730413T patent/SI0923550T1/xx unknown
- 1997-08-13 PT PT97918984T patent/PT923550E/pt unknown
- 1997-08-13 RU RU99106157/04A patent/RU2185375C2/ru not_active IP Right Cessation
- 1997-08-13 CA CA002264065A patent/CA2264065C/en not_active Expired - Fee Related
- 1997-08-13 NZ NZ334736A patent/NZ334736A/xx not_active IP Right Cessation
- 1997-08-13 KR KR10-1999-7001487A patent/KR100467402B1/ko not_active Expired - Fee Related
- 1997-08-13 IL IL12863197A patent/IL128631A/en not_active IP Right Cessation
- 1997-08-13 WO PCT/EP1997/004436 patent/WO1998007694A1/en not_active Ceased
- 1997-08-13 ES ES97918984T patent/ES2184083T3/es not_active Expired - Lifetime
- 1997-08-13 SK SK221-99A patent/SK283991B6/sk not_active IP Right Cessation
- 1997-08-13 HU HU0001165A patent/HU226395B1/hu not_active IP Right Cessation
- 1997-08-19 AR ARP970103747A patent/AR009266A1/es active IP Right Grant
- 1997-08-20 ID IDP972913A patent/ID18059A/id unknown
- 1997-08-20 PE PE1997000741A patent/PE107498A1/es not_active Application Discontinuation
- 1997-08-21 ZA ZA977493A patent/ZA977493B/xx unknown
- 1997-08-21 CO CO97048265A patent/CO4900047A1/es unknown
- 1997-08-22 TW TW086111854A patent/TW438777B/zh not_active IP Right Cessation
-
1999
- 1999-02-19 NO NO19990786A patent/NO312292B1/no not_active IP Right Cessation
- 1999-02-19 PL PL97331740A patent/PL193731B1/pl not_active IP Right Cessation
-
2000
- 2000-09-05 US US09/655,170 patent/US6319917B1/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE449849T1 (de) | Ob rezeptor-variante und liganden | |
| ATE223911T1 (de) | Benzothiophenecarboxamid-derivate und diese enthaltende pgd2 antagonisten | |
| DE69531458D1 (de) | Chinolinderivate als tachykinin nk3 rezeptor antagonisten | |
| ATE224875T1 (de) | Acylaminoalkenylen-amid-derivate als nk1 und nk2 antagonisten | |
| DE69615025D1 (de) | Benzamid-derivate und deren verwendung als vasopressin-antagonisten | |
| DE59601122D1 (de) | N-(Benzofurazanyl)-Arylsulfonamide und ihre Analoge verwendbar als Endothelin-Rezeptor-Antagonisten | |
| DE69731161D1 (de) | Kontroller und erweiterungseinheit dafür | |
| FI970107A7 (fi) | Heterosyklisiä takykiniinireseptoriantagonisteja | |
| EP0934305A4 (de) | Integrinantagonisten | |
| DE69818248D1 (de) | Chinolin- und chinazolin-derivate als crf antagonisten | |
| DE69728392D1 (de) | Indolderivate verwendbar als endothelinrezeptorantagonisten | |
| DE69720896D1 (de) | Tonerkammer und Arbeitseinheit | |
| EP0946164A4 (de) | Integrin antagonisten | |
| EP0885205A4 (de) | Fibrinogen-rezeptor-antagonisten | |
| FI963083A7 (fi) | Normotensiivisen glaukooman hoito angiotensiini-II-antagonisteilla | |
| ATE227724T1 (de) | Muscarinagonisten und antagonisten | |
| DE69816290D1 (de) | Chinolin-4-carboxamidderivate als nk-2 und nk-3 rezeptor antagonisten | |
| DE69626220D1 (de) | 3-azetidinylalkylpiperidine oder -pyrrolidine als tachykinin antagonisten | |
| DE69718786D1 (de) | Benzoxazinone als dopamine -d4- rezeptor-antagonisten | |
| AU1667500A (en) | N-(2-phenyl-4-piperidinybutyl)-5,6,7,8-tetrahydro-1-naphthal necarboxamides and their use as neurokinin 1 (nk1) and/or neurokinin 2 (nk2) receptor antagonists | |
| DE59808461D1 (de) | Oxazolidinone als 5-ht2a-antagonisten | |
| DE60011650D1 (de) | Synergistische kombination von nk1-rezeptor antagonisten und gaba analogen | |
| ATE325118T1 (de) | Piperazinoderivate als neurokinin-antagonisten | |
| ATE208764T1 (de) | Isazole derivate als fibrinogen-rezeptor- antagonisten | |
| EP0957908A4 (de) | Antagonisten des fibrinogen rezeptors |